427 related articles for article (PubMed ID: 18684198)
41. Temporal trend in relative risk of second primary colorectal cancer.
Das A; Chak A; Cooper GS
Am J Gastroenterol; 2006 Jun; 101(6):1342-7. PubMed ID: 16771959
[TBL] [Abstract][Full Text] [Related]
42. Predictive value of diminutive colonic adenoma trial: the PREDICT trial.
Schoenfeld P; Shad J; Ormseth E; Coyle W; Cash B; Butler J; Schindler W; Kikendall WJ; Furlong C; Sobin LH; Hobbs CM; Cruess D; Rex D;
Clin Gastroenterol Hepatol; 2003 May; 1(3):195-201. PubMed ID: 15017491
[TBL] [Abstract][Full Text] [Related]
43. Chronic statin therapy and the risk of colorectal cancer.
Yang YX; Hennessy S; Propert K; Hwang WT; Sarkar M; Lewis JD
Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):869-76. PubMed ID: 18412290
[TBL] [Abstract][Full Text] [Related]
44. Colorectal cancer in Russian-speaking Jewish emigrés: community-based screening.
Vadlamani A; Maher JF; Shaete M; Smirnoff A; Cameron DG; Winkelmann JC; Goldberg SJ
Am J Gastroenterol; 2001 Sep; 96(9):2755-60. PubMed ID: 11569707
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the Danish national strategy for selective use of colonoscopy in symptomatic outpatients without known risk factors for colorectal cancer.
Bjerregaard NC; Tøttrup A; Sørensen HT; Laurberg S
Scand J Gastroenterol; 2007 Feb; 42(2):228-36. PubMed ID: 17327943
[TBL] [Abstract][Full Text] [Related]
46. Physical activity and risk of colorectal cancer in Japanese men and women: the Japan Public Health Center-based prospective study.
Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Causes Control; 2007 Mar; 18(2):199-209. PubMed ID: 17206529
[TBL] [Abstract][Full Text] [Related]
47. [Change in location of colorectal cancer in Hungarian patients between 1993-2004].
Fuszek P; Horváth HC; Speer G; Papp J; Haller P; Halász J; Járay B; Székely E; Schaff Z; Papp A; Bursics A; Harsányi L; Lukovich P; Kupcsulik P; Hitre E; Lakatos PL
Orv Hetil; 2006 Apr; 147(16):741-6. PubMed ID: 16711260
[TBL] [Abstract][Full Text] [Related]
48. Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study.
Weijenberg MP; Aardening PW; de Kok TM; de Goeij AF; van den Brandt PA
Mutat Res; 2008 Mar; 652(1):54-64. PubMed ID: 18296105
[TBL] [Abstract][Full Text] [Related]
49. Risk of colorectal cancer after colonoscopy compared with flexible sigmoidoscopy or no lower endoscopy among older patients in the United States, 1998-2005.
Wang YR; Cangemi JR; Loftus EV; Picco MF
Mayo Clin Proc; 2013 May; 88(5):464-70. PubMed ID: 23522751
[TBL] [Abstract][Full Text] [Related]
50. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.
Jacobs EJ; Thun MJ; Bain EB; Rodriguez C; Henley SJ; Calle EE
J Natl Cancer Inst; 2007 Apr; 99(8):608-15. PubMed ID: 17440162
[TBL] [Abstract][Full Text] [Related]
51. Family history and age at initiation of colorectal cancer screening.
Brenner H; Hoffmeister M; Haug U
Am J Gastroenterol; 2008 Sep; 103(9):2326-31. PubMed ID: 18702651
[TBL] [Abstract][Full Text] [Related]
52. Colonoscopic screening of an average-risk population for colorectal neoplasia.
Boursi B; Halak A; Umansky M; Galzan L; Guzner-Gur H; Arber N
Endoscopy; 2009 Jun; 41(6):516-21. PubMed ID: 19533557
[TBL] [Abstract][Full Text] [Related]
53. Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis.
Shroff J; Thosani N; Batra S; Singh H; Guha S
World J Gastroenterol; 2014 Dec; 20(48):18466-76. PubMed ID: 25561818
[TBL] [Abstract][Full Text] [Related]
54. Acceptability and side-effects of colonoscopy and sigmoidoscopy in a screening setting.
Senore C; Ederle A; Fantin A; Andreoni B; Bisanti L; Grazzini G; Zappa M; Ferrero F; Marutti A; Giuliani O; Armaroli P; Segnan N
J Med Screen; 2011; 18(3):128-34. PubMed ID: 22045821
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of left-sided colorectal cancer and benefit of flexible sigmoidoscopy: a county hospital experience.
Kumar RR; King J; Holt A; Huynh R; Mittal R; Deen R; Kim J
Am Surg; 2007 Oct; 73(10):994-7. PubMed ID: 17983066
[TBL] [Abstract][Full Text] [Related]
56. Trends in colorectal cancer testing among Medicare subpopulations.
Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
[TBL] [Abstract][Full Text] [Related]
57. Retrospective analysis of pre- and peri-operative imaging in confirmed proximal colonic cancers--possible implications for screening flexible sigmoidoscopy.
Peravali R; Kandiah K; Surah A; Murria P; Taniere P; Radley S
Colorectal Dis; 2009 Feb; 11(2):146-9. PubMed ID: 18462247
[TBL] [Abstract][Full Text] [Related]
58. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II.
Rasmussen M; Fenger C; Kronborg O
Scand J Gastroenterol; 2003 Jan; 38(1):114-8. PubMed ID: 12608473
[TBL] [Abstract][Full Text] [Related]
60. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies.
Jess T; Gamborg M; Matzen P; Munkholm P; Sørensen TI
Am J Gastroenterol; 2005 Dec; 100(12):2724-9. PubMed ID: 16393226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
